Last Updated January 22, 2024

 January 22, 2024

For researchers curious about 5-amino-1MQ capsules, we have examined the clinical trials data on this potent molecule to create a thorough guide to 5-amino-1MQ capsules.

In this article, our research team addresses questions like:

  • What is 5-amino-1MQ?
  • What are the potential benefits of 5-amino-1MQ?
  • Is 5-amino-1MQ safe?
  • How should 5-amino-1MQ be dosed and stored?

In addition, we provide our top recommendation of a 5-amino-1MQ capsules supplier.

Read on to explore the current evidence on 5-amino-1MQ benefits and discover whether to include this powerful NNMT blocker in research.

Buy 5-amino 1MQ from our top-rated vendor...

Disclaimer: contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is 5-amino-1MQ?

Researchers at the University of Texas first characterized 5-amino-1MQ (5-amino-1-methyl quinolinium) in 2017 while searching for ways to inhibit nicotinamide-N-methyltransferase (NNMT) [1].

NNMT is an enzyme that is highly active in fat tissue and key to cellular metabolism and energy homeostasis. Notably, the enzyme has been linked to obesity and type 2 diabetes (T2D). The researchers thus hypothesized that blocking NNMT could open a novel path to treating obesity and its metabolic complications [1, 2].

5-amino-1MQ is a small, membrane-permeable molecule with a chemical formula of C10H11N2+. By inhibiting NNMT, 5-amino-1MQ improves glucose clearance from the blood and enables cells to more rapidly use available energy, reducing glycogen and fat deposition [1, 3].

The NNMT-blocking mechanism of 5-amino-1MQ has been shown to increase levels of the cofactor NAD+, whose replenishment in organisms promotes muscular, cognitive, and immune function, as well as increased lifespan [4, 5].

In a 2021 study in obese mice, 5-amino-1MQ administration caused significant body mass reductions in the rodents, who achieved body composition and liver adiposity parameters that were comparable to the lean mice in the control group. The study authors reinforced the idea that NNMT inhibition could potentially treat obesity and related metabolic comorbidities [6].

5-amino-1MQ has yet to enter clinical trials and accordingly is yet to be approved for human use by the United States Food and Drug Administration (“USFDA”).

At this time, 5-amino-1MQ is available to qualified researchers for in vitro testing and laboratory experimentation only.

5-Amino 1MQ Capsules

Benefits of 5-Amino-1MQ

While there are encouraging test tube and animal studies into the effects of 5-amino-1MQ, it is important to note that we still lack quality data in humans. Future research is expected to shed more light into the potential benefits and uses of this NNMT inhibitor.
For now, 5-amino-1MQ appears to be a promising candidate for treating obesity and diabetes, as well as improving muscle function.

5-Amino-1MQ for Weight Loss

By blocking NNMT, 5-amino-1MQ increases availability of NAD+ and influences metabolic processes that rely on this cofactor. This allows the body to burn more calories and suppress storing additional glycogen and fat deposits.

Research shows that increased NNMT is strongly associated with obesity, so targeting this enzyme could be beneficial for weight loss [2].

High activity of NNMT is also correlated with lower levels of glucose transporter 4 (GLUT4), which is vital for glucose uptake from the bloodstream into fat and muscle cells. When glucose transport is impaired, the body stores glycogen and fat because it cannot use all the energy, resulting in weight gain [7].

Subjects with high levels of GLUT4 have a “faster metabolism,” and their bodies burn more calories. The production of this transporter can be increased through exercise [8]. However, this remains challenging for many obese individuals.
5-amino-1MQ not only works to reduce NNMT but increases GLUT4 transporter expression. This result is improved glucose clearance from the blood, which supports energy metabolism and reduces fat storage [6].

In a seminal study in diet-induced obese mice, 5-amino-1MQ administration led to a 35% reduction in mass and size, a 30% decrease in adipocyte size, and a 40% decrease in adipocyte volume in the rodents. In addition, the treated mice showed cholesterol levels that were comparable to those of healthy mice. These findings were not attributed to variations in food intake, which implies that the observed results were mediated by alterations in metabolic processes [1].

5-Amino-1MQ for Diabetes and Metabolic Disorders

NNMT is a potential biomarker for reduced insulin sensitivity, since higher activity of this enzyme has been linked to insulin resistance and type 2 diabetes [9].

Inhibition of NNMT may thus improve glucose tolerance and insulin sensitivity. One study investigating these effects in obese mice discovered that administration of an NNMT blocker reduced insulin serum levels by 50-60% in the subjects. In addition, the mice experienced significant fat loss, reduced adipocyte size and volume, and decreased triglycerides and free fatty acids [10].

These findings highlight the potential of 5-amino-1MQ peptide therapy as a blood sugar management tool in diabetic and prediabetic individuals.

5-Amino-1MQ for Muscle Repair

Since 5-amino-1MQ inhibits NNMT in skeletal muscle and enhances the activity of GLUT4, the molecule may represent a promising intervention to improve workout capacity and physical performance.

Scientists are investigating how 5-amino-1MQ can affect stem cells and muscle repair. In a study in old mice, NNMT inhibition was shown to promote stem cell activation following injury. The 5-amino-1MQ-treated mice experienced a two-fold increase in myofiber size and cross-sectional area distribution. In addition, the 5-amino-1MQ group had 70% stronger contractile force in healed muscle compared to the control [11].

Higher NNMT levels have also been observed in patients with some forms of muscular dystrophy [12]. Scientists believe that inflammation linked to these conditions is what drives the increase of NNMT. An NNMT inhibitor like 5-amino-1MQ could help by stimulating the synthesis of NAD+, a vital cofactor in the electron transport chain. In addition, it appears that NAD+ protects muscles from metabolic and structural degeneration [13].

5-Amino-1MQ Side Effects

5-amino-1MQ has the potential to support weight loss by increasing energy metabolism and reducing fat storage. However, it is important to be aware of the molecule’s safety profile and potential side effects before administering it to test subjects.

While there is no data to establish the safety of 5-amino-1MQ in humans, rodent studies have found no significant adverse effects [1, 6, 11]. Considering that most current pharmacological treatments of obesity are linked to major side effects, the preclinical research into 5-amino-1MQ looks promising.

Independent researchers have reported that taking 5-amino-1MQ too late in the day may result in difficulty with falling asleep. It has also been reported that 5-amino-1MQ treatment requires an acclimation period, with some subjects reporting decreased exercise tolerance with cardiovascular exercise.

Given the limited safety information available on 5-amino-1MQ, researchers must consider excluding certain groups from their trials until we have more pre-clinical and clinical data.

This would include pregnant and breastfeeding subjects, those with chronic conditions, and those taking medications that can interact with 5-amino-1MQ.

5-Amino-1MQ Dosage Guide

Given its status as a research peptide, there are no official dosing guidelines and safety protocols in place for 5-amino-1MQ.

Researchers looking to investigate the effects of 5-amino-1MQ capsules are advised to consider all data available.

Here are some pointers to keep in mind when designing a 5-amino-1MQ dosing protocol.

  • The optimal administration schedule and dosage vary depending on the desired therapeutic outcome.
  • Dosages used in rodent studies range from 10mg/kg/day to 150mg/kg/day [1, 6, 11]. These doses, of course, do not scale to human subjects.
  • Independent researchers typically administer a daily 5-amino-1MQ dose of 50-150mg of 5-amino-1MQ to human subjects.
  • Quality, long-term data on 5-amino-1MQ is lacking. Researchers are accordingly advised to refrain from administering 5-amino-1MQ indefinitely. Independent researchers report study durations of four to eight weeks.

Sample 5-Amino-1MQ Dosing Protocol

Researchers using 50mg 5-amino-1MQ capsules for weight loss may refer to the following dosing protocol:

  • 5-amino-1MQ Dosage: 50mg-150mg per day. Since one capsule contains 50mg of 5-amino-1MQ, subjects require one to three capsules daily. The full dose may be taken once in the morning on an empty stomach, or split into two to three daily doses throughout the day, each on an empty stomach.
  • Course Duration: 1-2 months.
  • Notes: A 60-capsule container represents a 20-day supply at the 150mg/daily dose, a 40-day supply at the 100mg/daily dose, and a 60-day supply at the 50mg/daily dose.

We encourage researchers to stay up-to-date on the latest research regarding 5-amino-1MQ and NNMT blockers.

5-Amino-1MQ Capsules | What Researchers Need to Know

In this section, we take a deeper look into 5-amino-1MQ capsule characteristics, best practices for storage and administration, and how to select a reliable vendor of research capsules.

5-Amino-1MQ Structure and Bioavailability

The chemical formula of 5-amino-1MQ is C10H11N2+. It consists of a quinoline ring, which is a bicyclic aromatic system of a benzene and pyridine ring. The quinoline ring contains an amino group at position 5 and a methyl group at position 1 [3].

5-amino-1MQ is effective in capsule form as it is chemically stable and does not degrade during processing, transportation, and storage. In addition, 5-amino-1MQ is selective membrane-permeable, allowing our bodies to digest it so it can enter the bloodstream and cells. Animal research has confirmed the high oral bioavailability of 5-amino-1MQ, making it suitable for administration in capsule form [14].

5-Amino-1MQ Capsule Administration and Storage

Researchers should follow manufacturer’s instructions for the safe storage and administration of 5-amino-1MQ. While the molecule is stable at room temperature under normal conditions, different factors can affect the purity of this compound and cause degradation.

It is important to keep 5-amino-1MQ capsules in their original container, which is designed to protect the capsules from light, moisture, high temperatures, and other factors that can degrade the quality of the compound. To ensure shelf life, researchers should store the container in a cool, dry place, away from direct sunlight, heat, and moisture.

There is currently no established protocol for administering 5-amino-1MQ capsules. Some independent researchers recommend taking the full daily dose on an empty stomach, first thing in the morning. Others spread the daily dose into 2-3 doses, taken in the morning and prior to physical exercise, in both cases on an empty stomach.

Selecting a Reliable Vendor of Research Peptides

Researchers should always source 5-amino-1MQ capsules from a reputable vendor with transparent sourcing practices, ethical and compliant marketing, and laboratory test results available online. Not all research chemical vendors adhere to these practices, which is why researchers should perform due diligence when selecting the right vendor

Using peptides from questionable vendors may compromise the safety and effectiveness of the experiment. In addition, products from such vendors may contain impurities or harmful chemicals, increasing the risk of adverse effects.

When selecting a vendor of 5-amino-1MQ capsules, researchers will need to verify:

  • The vendor’s track record and customer reviews
  • Availability of third-party laboratory results
  • Shipping options and policies
  • Available payment options
  • Customer service quality

In addition, steer clear of online vendors who make unsupported claims regarding their products. Although 5-amino-1MQ displays high potential for clinical applications, quality data is still needed to establish its safety and efficacy.

5-Amino 1MQ Capsules

Where to Buy 5-Amino-1MQ Capsules Online? | 2024 Edition

5-amino-1MQ shows great potential in the treatment of obesity and related metabolic disorders. However, it is vital to purchase 5-amino-1MQ capsules from a legitimate vendor.

After comparing online peptide vendors, is proud to recommend the best 5-amino-1MQ capsules available online.

Limitless Life

We recommend visiting Limitless Life for 5-amino-1MQ capsules, and here is why:

  • Lab-Tested Peptides: Third-party lab testing is a must when ordering peptides from an online vendor. Limitless Life submits each product batch for independent lab testing and displays the results online. This reflects the vendor’s commitments to both transparency and product quality.
  • Convenient Payment Options: Limitless Life offers competitively priced 5-amino-1MQ with a range of discounts available depending on the payment option. They accept major credit cards, e-checks, crypto, and Cash App.
  • Fast and Reliable Shipping: Limitless Life reliably ships their products within the U.S. and to select international destinations. U.S.-based researchers can expect their purchases to be delivered in 2-3 business days, and they waive shipping on domestic orders over $350.
  • Friendly Customer Service: Limitless Life has a responsive and friendly customer service team ready to answer any questions via email or phone. In our experience, they respond to email inquiries within 24 hours and provide helpful information about their products.

Buy research peptides from Limitless Life, a top-rated vendor...

5-Amino-1MQ Capsules | Verdict

5-amino-1MQ capsules represent a potentially novel treatment of obesity, type 2 diabetes, and muscle wasting conditions. It works by inhibiting NNMT, an enzyme that regulates cellular energy metabolism and is mostly found in fat tissue.

By blocking this enzyme, 5-amino-1MQ has been shown to increase fat burning, improve glucose clearance, and prevent new fatty tissue deposits. The small molecule has also been shown to help lower blood cholesterol levels and stimulate muscle repair in animal studies, paving the way for a host of research applications.

Since this NNMT blocker has yet to enter clinical trials, its sale online is limited to qualified researchers and laboratory professionals.

To source 5-amino-1MQ capsules, turn to our top-rated vendor, an established leader within the research chemicals industry.


  1. Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jan;147:141-152. doi: 10.1016/j.bcp.2017.11.007. Epub 2017 Nov 15. PMID: 29155147; PMCID: PMC5826726.
  2. Liu M, Li L, Chu J, Zhu B, Zhang Q, Yin X, Jiang W, Dai G, Ju W, Wang Z, Yang Q, Fang Z. Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese. J Clin Endocrinol Metab. 2015 Aug;100(8):3112-7. doi: 10.1210/jc.2015-1732. Epub 2015 Jun 12. PMID: 26066674; PMCID: PMC4525009.
  3. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 950107, 5-Amino-1-methylquinolinium; [cited 2023 Mar. 9]. Available from:
  4. Verdin, E. (2015) “NAD + in aging, metabolism, and neurodegeneration,” Science, 350(6265), pp. 1208–1213. Available at:
  5. Belenky, P., Bogan, K.L. and Brenner, C. (2007) “NAD+ metabolism in health and disease,” Trends in Biochemical Sciences, 32(1), pp. 12–19. Available at:
  6. Sampson, C.M. et al. (2021) Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice, Nature News. Nature Publishing Group. Available at: (Accessed: March 9, 2023).
  7. Kim YB, Peroni OD, Aschenbach WG, Minokoshi Y, Kotani K, Zisman A, Kahn CR, Goodyear LJ, Kahn BB. Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Mol Cell Biol. 2005 Nov;25(21):9713-23. doi: 10.1128/MCB.25.21.9713-9723.2005. PMID: 16227617; PMCID: PMC1265843.
  8. Theresia M. Schnurr et al. (2015) The effect of acute exercise on GLUT4 levels in peripheral blood mononuclear cells of sled dogs, Biochemistry and Biophysics Reports. Elsevier. Available at: (Accessed: March 8, 2023).
  9. Kannt A, Pfenninger A, Teichert L, Tönjes A, Dietrich A, Schön MR, Klöting N, Blüher M. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia. 2015 Apr;58(4):799-808. doi: 10.1007/s00125-014-3490-7. Epub 2015 Jan 18. PMID: 25596852; PMCID: PMC4351435.
  10. Kraus, D., Yang, Q., Kong, D. et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508, 258–262 (2014).
  11. Neelakantan H, Brightwell CR, Graber TG, Maroto R, Wang HL, McHardy SF, Papaconstantinou J, Fry CS, Watowich SJ. Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle. Biochem Pharmacol. 2019 May;163:481-492. doi: 10.1016/j.bcp.2019.02.008. Epub 2019 Feb 10. PMID: 30753815; PMCID: PMC6469996.
  12. Pissios P. Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends Endocrinol Metab. 2017 May;28(5):340-353. doi: 10.1016/j.tem.2017.02.004. Epub 2017 Mar 11. PMID: 28291578; PMCID: PMC5446048.
  13. Ryu D, Zhang H, Ropelle ER, Sorrentino V, Mázala DA, Mouchiroud L, Marshall PL, Campbell MD, Ali AS, Knowels GM, Bellemin S, Iyer SR, Wang X, Gariani K, Sauve AA, Cantó C, Conley KE, Walter L, Lovering RM, Chin ER, Jasmin BJ, Marcinek DJ, Menzies KJ, Auwerx J. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci Transl Med. 2016 Oct 19;8(361):361ra139. doi: 10.1126/scitranslmed.aaf5504. PMID: 27798264; PMCID: PMC5535761.
  14. Ololade Awosemo, Harshini Neelakantan, Stanley Watowich, Jing Ma, Lei Wu, Diana S.-L. Chow, Dong Liang. Development & validation of LC–MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies, Journal of Pharmaceutical and Biomedical Analysis, Volume 204, 2021, 114255, ISSN 0731-7085, (

Scientifically Fact Checked by:

Dick Brashier, M.D.

Table of Contents
    Add a header to begin generating the table of contents